Elise Arline Olsen
Professor of Dermatology
Dr. Olsen is a faculty member of both the Departments of Dermatology and Medicine (Division of Hematologic Malignancies and Cellular Therapy) and a member of the Duke Cancer Institute and the Duke Clinical Research Institute. She is Founder and Director of the Duke Dermatopharmacology Study Center and has been involved in over 165 clinical studies for dermatological and oncologic indications. The studies have included Phase 1-IV, pharmaceutical, FDA, and FTC sponsored, and investigator initiated research protocols for multiple conditions.
Dr. Olsen's specific areas of expertise include cutaneous lymphoma and hair disorders. She is the Founder and Director of the Duke Cutaneous Lymphoma Research and Treatment Center and a member of the Duke Cancer Institute. She accepts referrals from dermatologists, oncologists and radiation oncologists for all types of cutaneous T and B cell lymphomas. She works closely with Duke dermatopathologists, radiation oncologists and oncologists experienced specifically in cutaneous lymphoma. She prescribes or coordinates all potential NCCN recommended treatments for cutaneous lymphoma including topical and systemic immunomodulators and chemotherapy, phototherapy, photopheresis, and radiation including total skin electron beam radiation. She is Founder and first President of the United States Cutaneous Lymphoma Consortium and the Chairman of the Registry Committee that has created the new national registry for all types of cutaneous lymphoma. She is the Past President and Secretary Treasurer of the International Society for Cutaneous Lymphoma and first author on the evaluation, classification, and clinical trial guidelines for the most common subtype of cutaneous lymphoma. She is Duke’s representative to the NCCN guidelines on T cell lymphomas.
Current Research Interests
Cicatricial alopecia including frontal fibrosing alopecia and central centrifugal cicatricial alopecia
Female pattern hair loss
Hair loss related to cancer therapy
Current Appointments & Affiliations
- Professor of Dermatology, Dermatology, Clinical Science Departments 1999
- Professor in Medicine, Medicine, Hematologic Malignancies and Cellular Therapy, Medicine 2012
- Member of the Duke Cancer Institute, Duke Cancer Institute, Institutes and Centers 1980
Contact Information
- 3346 Hospital South, Durham, NC 27710
- Duke Box 3294, Durham, NC 27710
- Background
-
Education, Training, & Certifications
- Resident, Dermatology, Duke University 1980 - 1983
- Resident, Internal Medicine, University of North Carolina - Chapel Hill 1978 - 1980
- M.D., Baylor University 1978
-
Previous Appointments & Affiliations
- Member in the Duke Clinical Research Institute, Duke Clinical Research Institute, Institutes and Centers 2003 - 2021
- Associate Professor of Medicine with tenure, Dermatology, Clinical Science Departments 1991 - 1998
- Assistant Professor of Medicine, Medicine, Clinical Science Departments 1985 - 1991
- Associate in the Department of Medicine, Medicine, Clinical Science Departments 1983 - 1985
-
Leadership & Clinical Positions at Duke
-
Founder and Director, Hair Disorders Research and Treatment Center
Founder and Director, Cutaneous Lymphoma Research and Treatment Center
Member, Duke University Standing Committee for Misconduct in Research
Duke's representative and President, Southeastern Consortium for Dermatology
-
Founder and Director, Hair Disorders Research and Treatment Center
- Recognition
-
Awards & Honors
- Honorary Membership. American Academy of Dermatology. March 2021
- David Whiting Research and Leadership Award. American Hair Research Society. March 2020
- Certificate of International Leadership. International League of Dermatologic Societies. 2018
- Vice President. American Academy of Dermatology. 2015
- Vice President. Women's Dermatologic Society. 2012
- Annual Litchfield Lecture . Dermatology Department, Oxford, Great Britain . 2010
- Founder and First President. United States Cutaneous Lymphoma Consortium. 2009
- Board of Directors. American Academy of Dermatology. 2008
- Keynote Speaker. Australian College of Dermatologists. 2007
- President. International Society for Cutaneous Lymphomas. 2005
- Secretary-Treasurer. International Society for Cutaneous Lymphomas. 2002
- President. North American Hair Research Society. 1999
- Secretary. Women's Dermatologic Society. 1997
- President and Founder. North Carolina Dermatology Association. 1994
- Chairman Steering Committee. Southeastern Consortium for Dermatology. 1991
- Expertise
-
Subject Headings
- Research
-
Selected Grants
- Safety and Efficacy of Naloxone Lotion for the Relief of Pruritus in Patients with Mycosis Fungoides (MF) awarded by Elorac Inc. 2017 - 2022
- United States Cutaneous Lymphoma Consortium (USCLC) National Cutaneous Lymphoma Registry to Advance and Optimize the Care and Treatment of Patients with Cutaneous Lymphoma awarded by US Consortium for Cutaneous Lymphomas 2016 - 2021
- Safety, efficacy and pharmacokinetics of CD11301 gel in early stage CTCL awarded by Galderma 2018 - 2021
- A Randomized, Double-blind, Vehicle-controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-50002 Topical Solution Administered Twice-Daily for 6 Months in Adult Subjects awarded by Aclaris Therapeutics Inc. 2018 - 2021
- USCLC/Duke CLRTC Think Tank on Clinical Trials in Primary Cutaneous Lymphoma awarded by Verastem Oncology 2019 - 2020
- A Controlled Double Blind Research Study Of The Bioavailab awarded by National Institutes of Health 1988 - 1989
-
External Relationships
- Advanced Consultative Services
- Affimed
- Arena Pharmaceuticals
- Cassiopia
- Foundation for the Advancement of Hair Disorders
- Kyowa Hakko Kirin Pharma, Inc.
- Leirion Foundation
- Otsuka Pharmaceuticals
- Pfizer Inc.
- Sologenix
- Southeastern Consortium for Dermatology
- United States Cutaneous Lymphoma Consortium
- UpToDate, Inc
- Publications & Artistic Works
-
Selected Publications
-
Academic Articles
-
Kim, Ellen J., Aaron R. Mangold, Jennifer A. DeSimone, Henry K. Wong, Lucia Seminario-Vidal, Joan Guitart, James Appel, et al. “Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides): The FLASH Phase 3 Randomized Clinical Trial.” Jama Dermatol 158, no. 9 (September 1, 2022): 1031–39. https://doi.org/10.1001/jamadermatol.2022.2749.Full Text Link to Item
-
Olsen, Elise A., Sean Whittaker, Rein Willemze, Lauren Pinter-Brown, Francine Foss, Larisa Geskin, Lawrence Schwartz, et al. “Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC.” Blood 140, no. 5 (August 4, 2022): 419–37. https://doi.org/10.1182/blood.2021012057.Full Text Link to Item
-
Sarver, Melissa M., Kimberly F. Breglio, and Elise A. Olsen. “Ataxia-telangiectasia mutated (ATM) gene mutation in a patient with primary cutaneous marginal zone lymphoma.” Jaad Case Rep 23 (May 2022): 73–75. https://doi.org/10.1016/j.jdcr.2022.02.032.Full Text Link to Item
-
Horwitz, Steven M., Stephen Ansell, Weiyun Z. Ai, Jeffrey Barnes, Stefan K. Barta, Jonathan Brammer, Mark W. Clemens, et al. “T-Cell Lymphomas, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.” J Natl Compr Canc Netw 20, no. 3 (March 2022): 285–308. https://doi.org/10.6004/jnccn.2022.0015.Full Text Link to Item
-
Olsen, E. A., M. Harries, A. Tosti, W. Bergfeld, U. Blume-Peytavi, V. Callender, V. Chasapi, et al. “Guidelines for clinical trials of frontal fibrosing alopecia: consensus recommendations from the International FFA Cooperative Group (IFFACG).” Br J Dermatol 185, no. 6 (December 2021): 1221–31. https://doi.org/10.1111/bjd.20567.Full Text Link to Item
-
Meah, Nekma, Dmitri Wall, Katherine York, Bevin Bhoyrul, Laita Bokhari, Daniel Asz-Sigall, Wilma F. Bergfeld, et al. “The Alopecia Areata Consensus of Experts (ACE) study part II: Results of an international expert opinion on diagnosis and laboratory evaluation for alopecia areata.” J Am Acad Dermatol 84, no. 6 (June 2021): 1594–1601. https://doi.org/10.1016/j.jaad.2020.09.028.Full Text Link to Item
-
Wall, Dmitri, Nekma Meah, Katherine York, Bevin Bhoyrul, Laita Bokhari, Leonardo Spagnol Abraham, Roisín Adams, et al. “A Global eDelphi Exercise to Identify Core Domains and Domain Items for the Development of a Global Registry of Alopecia Areata Disease Severity and Treatment Safety (GRASS).” Jama Dermatol 157, no. 4 (April 1, 2021): 1–11. https://doi.org/10.1001/jamadermatol.2020.5839.Full Text Link to Item
-
Horwitz, Steven M., Stephen Ansell, Weiyun Z. Ai, Jeffrey Barnes, Stefan K. Barta, Mark W. Clemens, Ahmet Dogan, et al. “NCCN Guidelines Insights: T-Cell Lymphomas, Version 1.2021.” J Natl Compr Canc Netw 18, no. 11 (November 2, 2020): 1460–67. https://doi.org/10.6004/jnccn.2020.0053.Full Text Link to Item
-
Zic, John A., Weiyun Ai, Oleg E. Akilov, Joi B. Carter, Madeleine Duvic, Francine Foss, Michael Girardi, et al. “United States Cutaneous Lymphoma Consortium recommendations for treatment of cutaneous lymphomas during the COVID-19 pandemic.” J Am Acad Dermatol 83, no. 2 (August 2020): 703–4. https://doi.org/10.1016/j.jaad.2020.04.049.Full Text Link to Item
-
Meah, Nekma, Dmitri Wall, Katherine York, Bevin Bhoyrul, Laita Bokhari, Daniel Asz Sigall, Wilma F. Bergfeld, et al. “The Alopecia Areata Consensus of Experts (ACE) study: Results of an international expert opinion on treatments for alopecia areata.” J Am Acad Dermatol 83, no. 1 (July 2020): 123–30. https://doi.org/10.1016/j.jaad.2020.03.004.Full Text Link to Item
-
Mehta-Shah, Neha, Steven M. Horwitz, Stephen Ansell, Weiyun Z. Ai, Jeffrey Barnes, Stefan K. Barta, Mark W. Clemens, et al. “NCCN Guidelines Insights: Primary Cutaneous Lymphomas, Version 2.2020.” J Natl Compr Canc Netw 18, no. 5 (May 2020): 522–36. https://doi.org/10.6004/jnccn.2020.0022.Full Text Link to Item
-
Olsen, Elise A., Deanna Kornacki, Kang Sun, and Maria K. Hordinsky. “Ruxolitinib cream for the treatment of patients with alopecia areata: A 2-part, double-blind, randomized, vehicle-controlled phase 2 study.” J Am Acad Dermatol 82, no. 2 (February 2020): 412–19. https://doi.org/10.1016/j.jaad.2019.10.016.Full Text Link to Item
-
Carmina, Enrico, Ricardo Azziz, Wilma Bergfeld, Héctor F. Escobar-Morreale, Walter Futterweit, Heather Huddleston, Rogerio Lobo, and Elise Olsen. “Female Pattern Hair Loss and Androgen Excess: A Report From the Multidisciplinary Androgen Excess and PCOS Committee.” J Clin Endocrinol Metab 104, no. 7 (July 1, 2019): 2875–91. https://doi.org/10.1210/jc.2018-02548.Full Text Link to Item
-
Olsen, Elise A., and David A. Whiting. “Focal atrichia: A diagnostic clue in female pattern hair loss.” J Am Acad Dermatol 80, no. 6 (June 2019): 1538-1543.e1. https://doi.org/10.1016/j.jaad.2017.09.064.Full Text Link to Item
-
Olsen, Elise A., Janet Roberts, Leonard Sperling, Antonella Tosti, Jerry Shapiro, Amy McMichael, Wilma Bergfeld, et al. “Objective outcome measures: Collecting meaningful data on alopecia areata.” J Am Acad Dermatol 79, no. 3 (September 2018): 470-478.e3. https://doi.org/10.1016/j.jaad.2017.10.048.Full Text Link to Item
-
Horwitz, Steven M., Stephen M. Ansell, Weiyun Z. Ai, Jeffrey Barnes, Stefan K. Barta, Michael Choi, Mark W. Clemens, et al. “NCCN Guidelines Insights: T-Cell Lymphomas, Version 2.2018.” J Natl Compr Canc Netw 16, no. 2 (February 2018): 123–35. https://doi.org/10.6004/jnccn.2018.0007.Full Text Link to Item
-
Guitart, Joan, M Estela Martinez-Escala, Antonio Subtil, Madeleine Duvic, Melissa P. Pulitzer, Elise A. Olsen, Ellen Kim, et al. “Primary cutaneous aggressive epidermotropic cytotoxic T-cell lymphomas: reappraisal of a provisional entity in the 2016 WHO classification of cutaneous lymphomas.” Mod Pathol 30, no. 5 (May 2017): 761–72. https://doi.org/10.1038/modpathol.2016.240.Full Text Link to Item
-
Bergfeld, Wilma F., Angela M. Christiano, Maria K. Hordinsky, and Maria K. Faculty of the Ninth World Congress of Hair Research. “Proceedings of the Ninth World Congress for Hair Research (2015).” J Investig Dermatol Symp Proc 18, no. 1 (2017): S1–28. https://doi.org/10.1016/j.jisp.2017.03.001.Full Text Link to Item
-
Olsen, Elise A., and Douglas Canfield. “SALT II: A new take on the Severity of Alopecia Tool (SALT) for determining percentage scalp hair loss.” J Am Acad Dermatol 75, no. 6 (December 2016): 1268–70. https://doi.org/10.1016/j.jaad.2016.08.042.Full Text Link to Item
-
Albrecht, Joerg, Mark Lebwohl, Maryam M. Asgari, Daniel D. Bennett, Ashley Cook, Colby C. Evans, Lawrence J. Green, et al. “The state and consequences of dermatology drug prices in the United States.” J Am Acad Dermatol 75, no. 3 (September 2016): 603–5. https://doi.org/10.1016/j.jaad.2016.03.053.Full Text Link to Item
-
Blume-Peytavi, Ulrike, Jerry Shapiro, Andrew G. Messenger, Maria K. Hordinsky, Paul Zhang, Carlos Quiza, Uday Doshi, and Elise A. Olsen. “Efficacy and Safety of Once-Daily Minoxidil Foam 5% Versus Twice-Daily Minoxidil Solution 2% in Female Pattern Hair Loss: A Phase III, Randomized, Investigator-Blinded Study.” J Drugs Dermatol 15, no. 7 (July 1, 2016): 883–89.Link to Item
-
Bichakjian, Christopher K., Thomas Olencki, Sumaira Z. Aasi, Murad Alam, James S. Andersen, Daniel Berg, Glen M. Bowen, et al. “Basal Cell Skin Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology.” J Natl Compr Canc Netw 14, no. 5 (May 2016): 574–97. https://doi.org/10.6004/jnccn.2016.0065.Full Text Link to Item
-
Olsen, Elise A., Emilia Hodak, Thomas Anderson, Joi B. Carter, Marsha Henderson, Kevin Cooper, and Henry W. Lim. “Guidelines for phototherapy of mycosis fungoides and Sézary syndrome: A consensus statement of the United States Cutaneous Lymphoma Consortium.” J Am Acad Dermatol 74, no. 1 (January 2016): 27–58. https://doi.org/10.1016/j.jaad.2015.09.033.Full Text Link to Item
-
Kim, Julie K., Adeel Ahmad, M Angelica Selim, Elise A. Olsen, and Adela R. Cardones. “Disseminated Cutaneous Cytomegalovirus Infection Following Total Body Electron Beam Irradiation for Mycosis Fungoides.” Jama Dermatol 151, no. 12 (December 1, 2015): 1380–81. https://doi.org/10.1001/jamadermatol.2015.2233.Full Text Link to Item
-
Olsen, Elise A. “Evaluation, Diagnosis, and Staging of Cutaneous Lymphoma.” Dermatol Clin 33, no. 4 (October 2015): 643–54. https://doi.org/10.1016/j.det.2015.06.001.Full Text Link to Item
-
Olsen, Elise A. “Cutaneous Lymphoma.” Dermatol Clin 33, no. 4 (October 2015): xiii. https://doi.org/10.1016/j.det.2015.07.001.Full Text Link to Item
-
Dummer, R., M. Duvic, J. Scarisbrick, E. A. Olsen, S. Rozati, N. Eggmann, S. M. Goldinger, et al. “Final results of a multicenter phase II study of the purine nucleoside phosphorylase (PNP) inhibitor forodesine in patients with advanced cutaneous T-cell lymphomas (CTCL) (Mycosis fungoides and Sézary syndrome).” Ann Oncol 25, no. 9 (September 2014): 1807–12. https://doi.org/10.1093/annonc/mdu231.Full Text Link to Item
-
Ogunleye, Temitayo A., Amy McMichael, and Elise A. Olsen. “Central centrifugal cicatricial alopecia: what has been achieved, current clues for future research.” Dermatol Clin 32, no. 2 (April 2014): 173–81. https://doi.org/10.1016/j.det.2013.12.005.Full Text Link to Item
-
Ladizinski, Barry, and Elise A. Olsen. “Red fingers syndrome in a patient with pseudolymphoma.” J Am Acad Dermatol 68, no. 6 (June 2013): e193–94. https://doi.org/10.1016/j.jaad.2012.11.027.Full Text Link to Item
-
Ladizinski, Barry, Andrea Bazakas, M Angelica Selim, and Elise A. Olsen. “Frontal fibrosing alopecia: a retrospective review of 19 patients seen at Duke University.” J Am Acad Dermatol 68, no. 5 (May 2013): 749–55. https://doi.org/10.1016/j.jaad.2012.09.043.Full Text Link to Item
-
Duvic, Madeleine, Ann G. Martin, Elise A. Olsen, David P. Fivenson, and H Miles Prince. “Efficacy and safety of denileukin diftitox retreatment in patients with relapsed cutaneous T-cell lymphoma.” Leuk Lymphoma 54, no. 3 (March 2013): 514–19. https://doi.org/10.3109/10428194.2012.720372.Full Text Link to Item
-
Ladizinski, Barry, and Elise A. Olsen. “Mycosis fungoides.” Mayo Clin Proc 88, no. 3 (March 2013): e27. https://doi.org/10.1016/j.mayocp.2012.12.009.Full Text Link to Item
-
Prince, H Miles, Ann G. Martin, Elise A. Olsen, David P. Fivenson, and Madeleine Duvic. “Denileukin diftitox for the treatment of CD25 low-expression mycosis fungoides and Sézary syndrome.” Leuk Lymphoma 54, no. 1 (January 2013): 69–75. https://doi.org/10.3109/10428194.2012.706286.Full Text Link to Item
-
Lessin, Stuart R., Madeleine Duvic, Joan Guitart, Amit G. Pandya, Bruce E. Strober, Elise A. Olsen, Christopher M. Hull, et al. “Topical chemotherapy in cutaneous T-cell lymphoma: positive results of a randomized, controlled, multicenter trial testing the efficacy and safety of a novel mechlorethamine, 0.02%, gel in mycosis fungoides.” Jama Dermatol 149, no. 1 (January 2013): 25–32. https://doi.org/10.1001/2013.jamadermatol.541.Full Text Link to Item
-
Guitart, Joan, Dennis D. Weisenburger, Antonio Subtil, Ellen Kim, Gary Wood, Madeleine Duvic, Elise Olsen, et al. “Cutaneous γδ T-cell lymphomas: a spectrum of presentations with overlap with other cytotoxic lymphomas.” Am J Surg Pathol 36, no. 11 (November 2012): 1656–65. https://doi.org/10.1097/PAS.0b013e31826a5038.Full Text Link to Item
-
Ladizinski, Barry, Andrea Bazakas, and Elise A. Olsen. “Aprepitant: a novel neurokinin-1 receptor/substance P antagonist as antipruritic therapy in cutaneous T-cell lymphoma.” J Am Acad Dermatol 67, no. 5 (November 2012): e198–99. https://doi.org/10.1016/j.jaad.2012.02.008.Full Text Link to Item
-
Chen, Alice P., Ann Setser, Milan J. Anadkat, Jonathan Cotliar, Elise A. Olsen, Benjamin C. Garden, and Mario E. Lacouture. “Grading dermatologic adverse events of cancer treatments: the Common Terminology Criteria for Adverse Events Version 4.0.” J Am Acad Dermatol 67, no. 5 (November 2012): 1025–39. https://doi.org/10.1016/j.jaad.2012.02.010.Full Text Link to Item
-
Olsen, Elise A., David A. Whiting, Ronald Savin, Anthony Rodgers, Amy O. Johnson-Levonas, Elizabeth Round, Jennifer Rotonda, Keith D. Kaufman, and Keith D. Male Pattern Hair Loss Study Group. “Global photographic assessment of men aged 18 to 60 years with male pattern hair loss receiving finasteride 1 mg or placebo.” J Am Acad Dermatol 67, no. 3 (September 2012): 379–86. https://doi.org/10.1016/j.jaad.2011.10.027.Full Text Link to Item
-
Singletary, Holly Leigh, M Angelica Selim, and Elise Olsen. “Subcutaneous interferon alfa for the treatment of cutaneous pseudolymphoma.” Arch Dermatol 148, no. 5 (May 2012): 572–74. https://doi.org/10.1001/archdermatol.2011.1016.Full Text Link to Item
-
Kempf, Werner, Katrin Pfaltz, Maarten H. Vermeer, Antonio Cozzio, Pablo L. Ortiz-Romero, Martine Bagot, Elise Olsen, et al. “EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.” Blood 118, no. 15 (October 13, 2011): 4024–35. https://doi.org/10.1182/blood-2011-05-351346.Full Text Link to Item
-
Olsen, E. A., and K. B. Reed. “Untangling the hairy issue of iron deficiency: Making progress.” Journal of the American Academy of Dermatology 65, no. 1 (July 1, 2011): 204–6. https://doi.org/10.1016/j.jaad.2011.03.001.Full Text
-
Foss, Francine, Madeleine Duvic, and Elise A. Olsen. “Predictors of complete responses with denileukin diftitox in cutaneous T-cell lymphoma.” Am J Hematol 86, no. 7 (July 2011): 627–30. https://doi.org/10.1002/ajh.22039.Full Text Link to Item
-
Olsen, Elise A., Sean Whittaker, Youn H. Kim, Madeleine Duvic, H Miles Prince, Stuart R. Lessin, Gary S. Wood, et al. “Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer.” J Clin Oncol 29, no. 18 (June 20, 2011): 2598–2607. https://doi.org/10.1200/JCO.2010.32.0630.Full Text Link to Item
-
Olsen, E. A. “Hair Disorders” 2 (May 24, 2011): 1–35. https://doi.org/10.1002/9781444345384.ch148.Full Text
-
Demierre, M. F., E. A. Olsen, C. A. Williams, J. M. Arduino, and K. S. McNaughton. “An in-depth assessment of the impact of pruritus on health-related quality of life of patients with mycosis fungoides/sézary syndrome.” Journal of Supportive Oncology 9, no. 3 (May 1, 2011). https://doi.org/10.1016/j.suponc.2011.02.001.Full Text
-
Olsen, Elise A., Alain H. Rook, John Zic, Youn Kim, Pierluigi Porcu, Christiane Querfeld, Gary Wood, et al. “Sézary syndrome: immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC).” J Am Acad Dermatol 64, no. 2 (February 2011): 352–404. https://doi.org/10.1016/j.jaad.2010.08.037.Full Text Link to Item
-
Olsen, Elise A., Valerie Callender, Amy McMichael, Leonard Sperling, Kevin J. Anstrom, Jerry Shapiro, Janet Roberts, Faith Durden, David Whiting, and Wilma Bergfeld. “Central hair loss in African American women: incidence and potential risk factors.” J Am Acad Dermatol 64, no. 2 (February 2011): 245–52. https://doi.org/10.1016/j.jaad.2009.11.693.Full Text Link to Item
-
Olsen, Elise A. “Investigative guidelines for alopecia areata.” Dermatol Ther 24, no. 3 (2011): 311–19. https://doi.org/10.1111/j.1529-8019.2011.01415.x.Full Text Link to Item
-
Yeager, Caroline E., and Elise A. Olsen. “Treatment of chemotherapy-induced alopecia.” Dermatol Ther 24, no. 4 (2011): 432–42. https://doi.org/10.1111/j.1529-8019.2011.01430.x.Full Text Link to Item
-
Olsen, Elise A., Katherine B. Reed, Patrick B. Cacchio, and Leslie Caudill. “Iron deficiency in female pattern hair loss, chronic telogen effluvium, and control groups.” J Am Acad Dermatol 63, no. 6 (December 2010): 991–99. https://doi.org/10.1016/j.jaad.2009.12.006.Full Text Link to Item
-
Olsen, Elise A. “The United States Cutaneous Lymphoma Consortium (USCLC).” Clin Lymphoma Myeloma Leuk 10 Suppl 2 (September 2010): S88–89. https://doi.org/10.3816/CLML.2010.s.015.Full Text Link to Item
-
Lacouture, Mario E., Michael L. Maitland, Siegfried Segaert, Ann Setser, Robert Baran, Lindy P. Fox, Joel B. Epstein, et al. “A proposed EGFR inhibitor dermatologic adverse event-specific grading scale from the MASCC skin toxicity study group.” Support Care Cancer 18, no. 4 (April 2010): 509–22. https://doi.org/10.1007/s00520-009-0744-x.Full Text Link to Item
-
Duvic, Madeleine, Elise A. Olsen, Debra Breneman, Theresa R. Pacheco, Sareeta Parker, Eric C. Vonderheid, Rachel Abuav, et al. “Evaluation of the long-term tolerability and clinical benefit of vorinostat in patients with advanced cutaneous T-cell lymphoma.” Clin Lymphoma Myeloma 9, no. 6 (December 2009): 412–16. https://doi.org/10.3816/CLM.2009.n.082.Full Text Link to Item
-
Anderson, Kyle A., Holly L. Bartell, and Elise A. Olsen. “Leukonychia related to vorinostat.” Arch Dermatol 145, no. 11 (November 2009): 1338–39. https://doi.org/10.1001/archdermatol.2009.272.Full Text Link to Item
-
Olsen, E. A. “Forodesine.” Haematologica Meeting Reports 3, no. 1 (September 9, 2009): 89.
-
Olsen, E. A. “Female pattern hair loss,” December 1, 2008, 171–86. https://doi.org/10.1007/978-3-540-46911-7_10.Full Text
-
Duvic, M., E. A. Olsen, D. Breneman, T. R. Pacheco, S. Parker, E. C. Vonderheid, J. L. Ricker, et al. “VORINOSTAT PROVIDES PROLONGED SAFETY AND CLINICAL BENEFIT TO PATIENTS WITH ADVANCED CUTANEOUS T-CELL LYMPHOMA (CTCL).” Haematologica the Hematology Journal 93 (June 1, 2008): 107–8.Link to Item
-
Olsen, E. A., S. Rizvi, J. Garcia-Vargas, C. Sanz-Rodriguez, J. Viscusi, M. Gates, and M. Duvic. “SUMMARY OF THE CLINICAL BENEFIT OF VORINOSTAT IN RELAPSED/REFRACTORY CTCL.” Haematologica the Hematology Journal 93 (June 1, 2008): 176–176.Link to Item
-
Olsen, E. A., M. Duvic, D. Breneman, T. R. Pacheco, S. Parker, E. C. Vonderheid, J. L. Ricker, S. Rizvi, K. Boileau, and L. J. Geskin. “Vorinostat provides prolonged safety and clinical benefit to patients with advanced cutaneous t-cell lymphoma (CTCL).” Journal of Clinical Oncology 26, no. 15_suppl (May 20, 2008): 14588–14588. https://doi.org/10.1200/jco.2008.26.15_suppl.14588.Full Text
-
Olsen, E. A., M. Duvic, D. Breneman, T. R. Pacheco, S. Parker, E. C. Vonderheid, J. L. Ricker, S. Rizvi, K. Boileau, and L. J. Geskin. “Vorinostat provides prolonged safety and clinical benefit to patients with advanced cutaneous t-cell lymphoma (CTCL).” J Clin Oncol 26, no. 15_suppl (May 20, 2008): 14588.Link to Item
-
Horwitz, Steven M., Elise A. Olsen, Madeleine Duvic, Pierliugi Porcu, and Youn H. Kim. “Review of the treatment of mycosis fungoides and sézary syndrome: a stage-based approach.” J Natl Compr Canc Netw 6, no. 4 (April 2008): 436–42. https://doi.org/10.6004/jnccn.2008.0033.Full Text Link to Item
-
Zelenetz, Andrew D., Ranjana H. Advani, John C. Byrd, Myron S. Czuczman, Lloyd E. Damon, Madeleine Duvic, Luis Fayad, et al. “Non-Hodgkin's lymphomas.” J Natl Compr Canc Netw 6, no. 4 (April 2008): 356–421. https://doi.org/10.6004/jnccn.2008.0030.Full Text Link to Item
-
Bellet, Jane S., Andrew L. Kaplan, M Angelica Selim, and Elise A. Olsen. “Keratosis follicularis spinulosa decalvans in a family.” J Am Acad Dermatol 58, no. 3 (March 2008): 499–502. https://doi.org/10.1016/j.jaad.2007.03.028.Full Text Link to Item
-
Price, Vera H., Maria K. Hordinsky, Elise A. Olsen, Janet L. Roberts, Elaine C. Siegfried, Elyse S. Rafal, Neil J. Korman, et al. “Subcutaneous efalizumab is not effective in the treatment of alopecia areata.” J Am Acad Dermatol 58, no. 3 (March 2008): 395–402. https://doi.org/10.1016/j.jaad.2007.10.645.Full Text Link to Item
-
Olsen, E. A., V. Callender, L. Sperling, A. McMichael, K. J. Anstrom, W. Bergfeld, F. Durden, J. Roberts, J. Shapiro, and D. A. Whiting. “Central scalp alopecia photographic scale in African American women.” Dermatol Ther 21, no. 4 (2008): 264–67. https://doi.org/10.1111/j.1529-8019.2008.00208.x.Full Text Link to Item
-
Olsen, Elise A. “Evaluation and treatment of hirsutism. Introduction.” Dermatol Ther 21, no. 5 (2008): 313. https://doi.org/10.1111/j.1529-8019.2008.00213.x.Full Text Link to Item
-
Whiting, David A., and Elise A. Olsen. “Central centrifugal cicatricial alopecia.” Dermatol Ther 21, no. 4 (2008): 268–78. https://doi.org/10.1111/j.1529-8019.2008.00209.x.Full Text Link to Item
-
Olsen, Elise A., David Whiting, Wilma Bergfeld, Jeffrey Miller, Maria Hordinsky, Rita Wanser, Paul Zhang, and Bruce Kohut. “A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men.” J Am Acad Dermatol 57, no. 5 (November 2007): 767–74. https://doi.org/10.1016/j.jaad.2007.04.012.Full Text Link to Item
-
Olsen, Elise, Eric Vonderheid, Nicola Pimpinelli, Rein Willemze, Youn Kim, Robert Knobler, Herschel Zackheim, et al. “Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC).” Blood 110, no. 6 (September 15, 2007): 1713–22. https://doi.org/10.1182/blood-2007-03-055749.Full Text Link to Item
-
Olsen, Elise A., Youn H. Kim, Timothy M. Kuzel, Theresa R. Pacheco, Francine M. Foss, Sareeta Parker, Stanley R. Frankel, et al. “Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma.” J Clin Oncol 25, no. 21 (July 20, 2007): 3109–15. https://doi.org/10.1200/JCO.2006.10.2434.Full Text Link to Item
-
Kim, Youn H., Rein Willemze, Nicola Pimpinelli, Sean Whittaker, Elise A. Olsen, Annamari Ranki, Reinhard Dummer, Richard T. Hoppe, and Richard T. ISCL and the EORTC. “TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC).” Blood 110, no. 2 (July 15, 2007): 479–84. https://doi.org/10.1182/blood-2006-10-054601.Full Text Link to Item
-
Olsen, Elise A., Maria Hordinsky, David Whiting, Dow Stough, Stuart Hobbs, Melissa L. Ellis, Timothy Wilson, Roger S. Rittmaster, and Roger S. Dutasteride Alopecia Research Team. “The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride.” J Am Acad Dermatol 55, no. 6 (December 2006): 1014–23. https://doi.org/10.1016/j.jaad.2006.05.007.Full Text Link to Item
-
Duvic, Madeleine, Andres Forero-Torres, Francine Foss, Elsie A. Olsen, and Youn Kim. “Oral Forodesine (Bcx-1777) Is Clinically Active in Refractory Cutaneous T-Cell Lymphoma: Results of a Phase I/II Study.” Blood 108, no. 11 (November 1, 2006): 2467–2467. https://doi.org/10.1182/blood.v108.11.2467.2467.Full Text
-
Duvic, Madeleine, Matthew L. Sherman, Gary S. Wood, Timothy M. Kuzel, Elise Olsen, Francine Foss, Robert J. Laliberté, John L. Ryan, Kristilyn Zonno, and Alain H. Rook. “A phase II open-label study of recombinant human interleukin-12 in patients with stage IA, IB, or IIA mycosis fungoides.” J Am Acad Dermatol 55, no. 5 (November 2006): 807–13. https://doi.org/10.1016/j.jaad.2006.06.038.Full Text Link to Item
-
Olsen, Elise A. “Iron deficiency and hair loss: the jury is still out.” J Am Acad Dermatol 54, no. 5 (May 2006): 903–6. https://doi.org/10.1016/j.jaad.2005.10.038.Full Text Link to Item
-
Olsen, Elise A. “Female pattern hair loss and its relationship to permanent/cicatricial alopecia: a new perspective.” J Investig Dermatol Symp Proc 10, no. 3 (December 2005): 217–21. https://doi.org/10.1111/j.1087-0024.2005.10109.x.Full Text Link to Item
-
Pimpinelli, Nicola, Elise A. Olsen, Marco Santucci, Eric Vonderheid, Andreas C. Haeffner, Seth Stevens, Guenter Burg, et al. “Defining early mycosis fungoides.” J Am Acad Dermatol 53, no. 6 (December 2005): 1053–63. https://doi.org/10.1016/j.jaad.2005.08.057.Full Text Link to Item
-
Antaya, Richard J., Eirini Sideridou, and Elise A. Olsen. “Short anagen syndrome.” J Am Acad Dermatol 53, no. 2 Suppl 1 (August 2005): S130–34. https://doi.org/10.1016/j.jaad.2004.12.029.Full Text Link to Item
-
Olsen, Elise A., Andrew G. Messenger, Jerry Shapiro, Wilma F. Bergfeld, Maria K. Hordinsky, Janet L. Roberts, Dow Stough, Ken Washenik, and David A. Whiting. “Evaluation and treatment of male and female pattern hair loss.” J Am Acad Dermatol 52, no. 2 (February 2005): 301–11. https://doi.org/10.1016/j.jaad.2004.04.008.Full Text Link to Item
-
Olsen, E. A. “Update on the diagnosis and treatment of common causes of alopecia and potential interaction of hair cosmetics.” Journal of Cosmetic Science 55, no. 5 (September 1, 2004): 492–93.
-
Olsen, E. A., M. K. Hordinsky, V. H. Price, J. L. Roberts, J. Shapiro, D. Canfield, M. Duvic, et al. “Alopecia areata investigational assessment guidelines-Part II.” Journal of the American Academy of Dermatology 51, no. 3 (September 1, 2004): 448–51. https://doi.org/10.1016/j.jaad.2004.04.005.Full Text
-
Olsen, Elise A., Maria K. Hordinsky, Vera H. Price, Janet L. Roberts, Jerry Shapiro, Doug Canfield, Madeleine Duvic, et al. “Alopecia areata investigational assessment guidelines--Part II. National Alopecia Areata Foundation.” J Am Acad Dermatol 51, no. 3 (September 2004): 440–47. https://doi.org/10.1016/j.jaad.2003.09.032.Full Text Link to Item
-
Duvic, M., S. Ziari, E. A. Olsen, and F. M. Foss. “Phase 1-2 multi-center study of intravenous Bcx-1777 in patients with refractory cutaneous T-cell lymphoma.” J Clin Oncol 22, no. 14_suppl (July 15, 2004): 6733.Link to Item
-
Kaplan, Andrew L., and Elise A. Olsen. “Topical 5-fluorouracil is ineffective in the treatment of extensive alopecia areata.” J Am Acad Dermatol 50, no. 6 (June 2004): 941–43. https://doi.org/10.1016/j.jaad.2004.01.046.Full Text Link to Item
-
Rook, Alain H., Timothy M. Kuzel, and Elise A. Olsen. “Cytokine therapy of cutaneous T-cell lymphoma: interferons, interleukin-12, and interleukin-2.” Hematol Oncol Clin North Am 17, no. 6 (December 2003): 1435–ix. https://doi.org/10.1016/s0889-8588(03)00109-6.Full Text Link to Item
-
Olsen, E., K. Stenn, W. Bergfeld, G. Cotsarelis, V. Price, J. Shapiro, R. Sinclair, A. Solomon, L. Sperling, and D. Whiting. “Update on cicatricial alopecia.” J Investig Dermatol Symp Proc 8, no. 1 (June 2003): 18–19. https://doi.org/10.1046/j.1523-1747.2003.12166.x.Full Text Link to Item
-
Olsen, Elise A. “Current and novel methods for assessing efficacy of hair growth promoters in pattern hair loss.” J Am Acad Dermatol 48, no. 2 (February 2003): 253–62. https://doi.org/10.1067/mjd.2003.81.Full Text Link to Item
-
Olsen, Elise A. “Interferon in the treatment of cutaneous T-cell lymphoma.” Dermatol Ther 16, no. 4 (2003): 311–21. https://doi.org/10.1111/j.1396-0296.2003.01643.x.Full Text Link to Item
-
Olsen, Elise A., Wilma F. Bergfeld, George Cotsarelis, Vera H. Price, Jerry Shapiro, Rodney Sinclair, Alvin Solomon, et al. “Summary of North American Hair Research Society (NAHRS)-sponsored Workshop on Cicatricial Alopecia, Duke University Medical Center, February 10 and 11, 2001.” J Am Acad Dermatol 48, no. 1 (January 2003): 103–10. https://doi.org/10.1067/mjd.2003.68.Full Text Link to Item
-
Whiting, David A., Elise A. Olsen, Ronald Savin, Lee Halper, Anthony Rodgers, Lixia Wang, Carolynn Hustad, Joanne Palmisano, and Joanne Male Pattern Hair Loss Study Group. “Efficacy and tolerability of finasteride 1 mg in men aged 41 to 60 years with male pattern hair loss.” Eur J Dermatol 13, no. 2 (2003): 150–60.Link to Item
-
Olsen, Elise A., Maria Hordinsky, Janet L. Roberts, David A. Whiting, and David A. Dermatologic Consortium for Women’s Health. “Female pattern hair loss.” J Am Acad Dermatol 47, no. 5 (November 2002): 795. https://doi.org/10.1067/mjd.2002.124068.Full Text Link to Item
-
Tosti, Antonella, Bianca Maria Piraccini, Wilma F. Bergfeld, Francisco Camacho, Rodney P. R. Dawber, Rudolf Happle, Elise A. Olsen, et al. “Occupational alopecia or alopecia areata?” J Am Acad Dermatol 47, no. 4 (October 2002): 636–37. https://doi.org/10.1067/mjd.2002.122739.Full Text Link to Item
-
Olsen, Elise A., Frank E. Dunlap, Toni Funicella, Judith A. Koperski, James M. Swinehart, Eduardo H. Tschen, and Ronald J. Trancik. “A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men.” J Am Acad Dermatol 47, no. 3 (September 2002): 377–85. https://doi.org/10.1067/mjd.2002.124088.Full Text Link to Item
-
Duvic, Madeleine, Timothy M. Kuzel, Elise A. Olsen, Ann G. Martin, Francine M. Foss, Youn H. Kim, Peter W. Heald, Patricia Bacha, Jean Nichols, and Astra Liepa. “Quality-of-life improvements in cutaneous T-cell lymphoma patients treated with denileukin diftitox (ONTAK).” Clin Lymphoma 2, no. 4 (March 2002): 222–28. https://doi.org/10.3816/clm.2002.n.003.Full Text Link to Item
-
Olsen, Elise A. “My hair is thinning on the top of my head. What treatments are available for hair loss in women?” Health News 8, no. 3 (March 2002): 12.Link to Item
-
Vonderheid, Eric C., Maria Grazia Bernengo, Günter Burg, Madeleine Duvic, Peter Heald, Liliane Laroche, Elise Olsen, et al. “Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas.” J Am Acad Dermatol 46, no. 1 (January 2002): 95–106. https://doi.org/10.1067/mjd.2002.118538.Full Text Link to Item
-
Rook, A. H., M. H. Zaki, M. Wysocka, G. S. Wood, M. Duvic, L. C. Showe, F. Foss, et al. “The role for interleukin-12 therapy of cutaneous T cell lymphoma.” Ann N Y Acad Sci 941 (September 2001): 177–84. https://doi.org/10.1111/j.1749-6632.2001.tb03721.x.Full Text Link to Item
-
Olsen, E. A. “Female pattern hair loss.” J Am Acad Dermatol 45, no. 3 Suppl (September 2001): S70–80. https://doi.org/10.1067/mjd.2001.117426.Full Text Link to Item
-
Duvic, M., E. A. Olsen, G. A. Omura, J. C. Maize, E. C. Vonderheid, C. A. Elmets, J. L. Shupack, M. F. Demierre, T. M. Kuzel, and D. Y. Sanders. “A phase III, randomized, double-blind, placebo-controlled study of peldesine (BCX-34) cream as topical therapy for cutaneous T-cell lymphoma.” J Am Acad Dermatol 44, no. 6 (June 2001): 940–47. https://doi.org/10.1067/mjd.2001.113478.Full Text Link to Item
-
Duvic, M., A. G. Martin, Y. Kim, E. Olsen, G. S. Wood, C. A. Crowley, R. C. Yocum, and R. C. Worldwide Bexarotene Study Group. “Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma.” Arch Dermatol 137, no. 5 (May 2001): 581–93.Link to Item
-
Olsen, E., M. Duvic, A. Frankel, Y. Kim, A. Martin, E. Vonderheid, B. Jegasothy, et al. “Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma.” J Clin Oncol 19, no. 2 (January 15, 2001): 376–88. https://doi.org/10.1200/JCO.2001.19.2.376.Full Text Link to Item
-
Olsen, E. A. “Female pattern hair loss: Clinical features and potential hormonal factors.” Journal of the American Academy of Dermatology 45, no. 3 (January 1, 2001): S69. https://doi.org/10.1067/mjd.2001.117631.Full Text
-
Price, V. H., J. L. Roberts, M. Hordinsky, E. A. Olsen, R. Savin, W. Bergfeld, V. Fiedler, et al. “Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia.” J Am Acad Dermatol 43, no. 5 Pt 1 (November 2000): 768–76. https://doi.org/10.1067/mjd.2000.107953.Full Text Link to Item
-
Olsen, E. A., M. S. Bettencourt, and N. L. Coté. “The presence of loose anagen hairs obtained by hair pull in the normal population.” J Investig Dermatol Symp Proc 4, no. 3 (December 1999): 258–60. https://doi.org/10.1038/sj.jidsp.5640225.Full Text Link to Item
-
Roberts, J. L., V. Fiedler, J. Imperato-McGinley, D. Whiting, E. Olsen, J. Shupack, D. Stough, et al. “Clinical dose ranging studies with finasteride, a type 2 5alpha-reductase inhibitor, in men with male pattern hair loss.” J Am Acad Dermatol 41, no. 4 (October 1999): 555–63.Link to Item
-
Bettencourt, M. S., and E. A. Olsen. “Pityriasis amiantacea: a report of two cases in adults.” Cutis 64, no. 3 (September 1999): 187–89.Link to Item
-
Olsen, E. A. “Efficacy of finasteride 1 mg in the treatment of androgenetic alopecia in men.” Exp Dermatol 8, no. 4 (August 1999): 302–3.Link to Item
-
Olsen, E. A. “Methods of hair removal.” J Am Acad Dermatol 40, no. 2 Pt 1 (February 1999): 143–55. https://doi.org/10.1016/s0190-9622(99)70181-7.Full Text Link to Item
-
Olsen, E., M. Hordinsky, S. McDonald-Hull, V. Price, J. Roberts, J. Shapiro, and K. Stenn. “Alopecia areata investigational assessment guidelines. National Alopecia Areata Foundation.” J Am Acad Dermatol 40, no. 2 Pt 1 (February 1999): 242–46. https://doi.org/10.1016/s0190-9622(99)70195-7.Full Text Link to Item
-
Olsen, E. A. “The midline part: an important physical clue to the clinical diagnosis of androgenetic alopecia in women.” J Am Acad Dermatol 40, no. 1 (January 1999): 106–9. https://doi.org/10.1016/s0190-9622(99)70539-6.Full Text Link to Item
-
Olsen, E. A. “Hair removal in hirsutism.” Dermatologic Therapy 8 (December 1, 1998): 68–72.
-
Olsen, E. A. “The diagnosis of androgenetic alopecia.” Dermatologic Therapy 8 (December 1, 1998): 18–23.
-
Kaufman, K. D., E. A. Olsen, D. Whiting, R. Savin, R. DeVillez, W. Bergfeld, V. H. Price, et al. “Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group.” J Am Acad Dermatol 39, no. 4 Pt 1 (October 1998): 578–89. https://doi.org/10.1016/s0190-9622(98)70007-6.Full Text Link to Item
-
Koo, J. “A randomized, double-blind study comparing the efficacy, safety and optimal dose of two formulations of cyclosporin, Neoral and Sandimmun, in patients with severe psoriasis. OLP302 Study Group.” Br J Dermatol 139, no. 1 (July 1998): 88–95. https://doi.org/10.1046/j.1365-2133.1998.02319.x.Full Text Link to Item
-
Olsen, E. A., M. Duvic, and A. Martin. “Pivotal phase III trial of two dose levels of DAB(389)IL-2 (ONTAK (TM)) for the treatment of cutaneous T-cell lymphoma (CTCL).” Journal of Investigative Dermatology 110, no. 4 (April 1, 1998): 678–678.Link to Item
-
Olsen, E. A., H. I. Katz, N. Levine, T. P. Nigra, P. E. Pochi, R. C. Savin, J. Shupack, G. D. Weinstein, L. Lufrano, and B. H. Perry. “Tretinoin emollient cream for photodamaged skin: results of 48-week, multicenter, double-blind studies.” J Am Acad Dermatol 37, no. 2 Pt 1 (August 1997): 217–26. https://doi.org/10.1016/s0190-9622(97)80128-4.Full Text Link to Item
-
Olsen, E. A., H. I. Katz, N. Levine, T. P. Nigra, P. E. Pochi, R. C. Savin, J. Shupack, G. D. Weinstein, L. Lufrano, and H. C. Jou. “Sustained improvement in photodamaged skin with reduced tretinoin emollient cream treatment regimen: effect of once-weekly and three-times-weekly applications.” J Am Acad Dermatol 37, no. 2 Pt 1 (August 1997): 227–30. https://doi.org/10.1016/s0190-9622(97)80129-6.Full Text Link to Item
-
Greiner, D., E. A. Olsen, and G. Petroni. “Pentostatin (2'-deoxycoformycin) in the treatment of cutaneous T-cell lymphoma.” J Am Acad Dermatol 36, no. 6 Pt 1 (June 1997): 950–55. https://doi.org/10.1016/s0190-9622(97)80279-4.Full Text Link to Item
-
Drake, L. A., S. M. Dinehart, E. R. Farmer, R. W. Goltz, G. F. Graham, M. K. Hordinsky, C. W. Lewis, et al. “Guidelines of care for the use of topical glucocorticosteroids. American Academy of Dermatology.” J Am Acad Dermatol 35, no. 4 (October 1996): 615–19. https://doi.org/10.1016/s0190-9622(96)90690-8.Full Text Link to Item
-
Hitchcock, M. G., J. L. Burchette, E. A. Olsen, H. Ratech, and H. Kamino. “Eccrine gland infiltration by mycosis fungoides.” Am J Dermatopathol 18, no. 5 (October 1996): 447–53. https://doi.org/10.1097/00000372-199610000-00001.Full Text Link to Item
-
Drake, L. A., S. M. Dinehart, E. R. Farmer, R. W. Goltz, G. F. Graham, M. K. Hordinsky, C. W. Lewis, et al. “Guidelines of care for androgenetic alopecia. American Academy of Dermatology.” J Am Acad Dermatol 35, no. 3 Pt 1 (September 1996): 465–69.Link to Item
-
Bhawan, J., E. Olsen, L. Lufrano, E. G. Thorne, B. Schwab, and B. A. Gilchrest. “Histologic evaluation of the long term effects of tretinoin on photodamaged skin.” J Dermatol Sci 11, no. 3 (March 1996): 177–82. https://doi.org/10.1016/0923-1811(95)00432-7.Full Text Link to Item
-
Olsen, E. A. “Efficacy and safety of fluticasone propionate 0.005% ointment in the treatment of psoriasis.” Cutis 57, no. 2 Suppl (February 1996): 57–61.Link to Item
-
Olsen, E. A., and P. A. Bunn. “Interferon in the treatment of cutaneous T-cell lymphoma.” Hematol Oncol Clin North Am 9, no. 5 (October 1995): 1089–1107.Link to Item
-
Epstein, E. “Warning! Masoprocol is a potent sensitizer.” J Am Acad Dermatol 31, no. 2 Pt 1 (August 1994): 295–97. https://doi.org/10.1016/s0190-9622(08)81988-3.Full Text Link to Item
-
Olsen, E. A., M. L. Abernethy, C. Kulp-Shorten, J. P. Callen, S. D. Glazer, A. Huntley, M. McCray, A. B. Monroe, E. Tschen, and J. E. Wolf. “Reply.” Journal of the American Academy of Dermatology 31, no. 2 (January 1, 1994): 296–97. https://doi.org/10.1016/S0190-9622(08)81989-5.Full Text
-
Borowitz, M. J., A. Weidner, E. A. Olsen, and L. J. Picker. “Abnormalities of circulating T-cell subpopulations in patients with cutaneous T-cell lymphoma: cutaneous lymphocyte-associated antigen expression on T cells correlates with extent of disease.” Leukemia 7, no. 6 (June 1993): 859–63.Link to Item
-
Hill, T. G. “Tretinoin emollient cream.” J Am Acad Dermatol 28, no. 2 Pt 1 (February 1993): 283–84. https://doi.org/10.1016/s0190-9622(08)81168-1.Full Text Link to Item
-
Olsen, E. A., H. I. Katz, N. Levine, J. Shupack, S. Prawer, M. Stiller, L. Lufrano, and E. G. Thorne. “Reply.” Journal of the American Academy of Dermatology 28, no. 2 (January 1, 1993): 283–84. https://doi.org/10.1016/S0190-9622(08)81169-3.Full Text
-
Olsen, E. A., S. C. Carson, and E. A. Turney. “Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata.” Arch Dermatol 128, no. 11 (November 1992): 1467–73.Link to Item
-
Olsen, E. A. “Human test models for bioequivalence of topical corticosteroids: a review.” Int J Dermatol 31 Suppl 1 (October 1992): 9–13. https://doi.org/10.1111/j.1365-4362.1992.tb04006.x.Full Text Link to Item
-
Grevelink, S. A., D. F. Murrell, and E. A. Olsen. “Effectiveness of various barrier preparations in preventing and/or ameliorating experimentally produced Toxicodendron dermatitis.” J Am Acad Dermatol 27, no. 2 Pt 1 (August 1992): 182–88. https://doi.org/10.1016/0190-9622(92)70167-e.Full Text Link to Item
-
Darwin, B. S., A. J. Herzberg, J. C. Murray, and E. A. Olsen. “Generalized papular xanthomatosis in mycosis fungoides.” J Am Acad Dermatol 26, no. 5 Pt 2 (May 1992): 828–32. https://doi.org/10.1016/0190-9622(92)70115-v.Full Text Link to Item
-
Olsen, E. A., H. I. Katz, N. Levine, J. Shupack, M. M. Billys, S. Prawer, J. Gold, M. Stiller, L. Lufrano, and E. G. Thorne. “Tretinoin emollient cream: a new therapy for photodamaged skin.” J Am Acad Dermatol 26, no. 2 Pt 1 (February 1992): 215–24. https://doi.org/10.1016/0190-9622(92)70030-j.Full Text Link to Item
-
De Bersaques, J., J. R. Bjerke, S. Borelli, A. C. Brown, F. Cottenot, F. Daniel, B. Dupont, et al. “Comparison of oral fluconazole and topical clotrimazole in the treatment of fungal infections of the skin: European and American experience.” International Journal of Dermatology 31, no. SUPPL. 2 (January 1, 1992): 21–26.
-
Grevelink, S. A., G. N. Fuller, and E. A. Olsen. “Central nervous system involvement by cutaneous T cell lymphoma.” J Am Acad Dermatol 25, no. 3 (September 1991): 542–49. https://doi.org/10.1016/0190-9622(91)70237-v.Full Text Link to Item
-
Olsen, E. A. “Topical minoxidil in the treatment of androgenetic alopecia in women.” Cutis 48, no. 3 (September 1991): 243–48.Link to Item
-
Olsen, E. A. “The pharmacology of methotrexate.” Journal of the American Academy of Dermatology 25, no. 2 Pt 1 (August 1991): 306–18. https://doi.org/10.1016/0190-9622(91)70199-c.Full Text
-
Olsen, E. A., M. L. Abernethy, C. Kulp-Shorten, J. P. Callen, S. D. Glazer, A. Huntley, M. McCray, A. B. Monroe, E. Tschen, and J. E. Wolf. “A double-blind, vehicle-controlled study evaluating masoprocol cream in the treatment of actinic keratoses on the head and neck.” J Am Acad Dermatol 24, no. 5 Pt 1 (May 1991): 738–43. https://doi.org/10.1016/0190-9622(91)70113-g.Full Text Link to Item
-
Olsen, E. A., D. L. Cram, C. N. Ellis, J. G. Hickman, C. Jacobson, E. E. Jenkins, A. E. Lasser, M. Lebwohl, E. Leibsohn, and R. S. Medansky. “A double-blind, vehicle-controlled study of clobetasol propionate 0.05% (Temovate) scalp application in the treatment of moderate to severe scalp psoriasis.” J Am Acad Dermatol 24, no. 3 (March 1991): 443–47. https://doi.org/10.1016/0190-9622(91)70069-e.Full Text Link to Item
-
Olsen, E. A. “A double-blind controlled comparison of generic and trade-name topical steroids using the vasoconstriction assay.” Arch Dermatol 127, no. 2 (February 1991): 197–201.Link to Item
-
Vernon, H. J., and E. A. Olsen. “A controlled trial of clobetasol propionate ointment 0.05% in the treatment of experimentally induced Rhus dermatitis.” J Am Acad Dermatol 23, no. 5 Pt 1 (November 1990): 829–32. https://doi.org/10.1016/0190-9622(90)70297-u.Full Text Link to Item
-
Olsen, E. A., and E. DeLong. “Transdermal viprostol in the treatment of male pattern baldness.” J Am Acad Dermatol 23, no. 3 Pt 1 (September 1990): 470–72. https://doi.org/10.1016/0190-9622(90)70242-a.Full Text Link to Item
-
Berg, D., D. H. Weingold, K. G. Abson, and E. A. Olsen. “Sweating in ectodermal dysplasia syndromes. A review.” Arch Dermatol 126, no. 8 (August 1990): 1075–79.Link to Item
-
Olsen, E. A., M. S. Weiner, I. A. Amara, and E. R. DeLong. “Five-year follow-up of men with androgenetic alopecia treated with topical minoxidil.” J Am Acad Dermatol 22, no. 4 (April 1990): 643–46. https://doi.org/10.1016/0190-9622(90)70089-z.Full Text Link to Item
-
Olsen, E. A., T. A. Buller, S. Weiner, and E. R. Delong. “Natural history of androgenetic alopecia.” Clin Exp Dermatol 15, no. 1 (January 1990): 34–36. https://doi.org/10.1111/j.1365-2230.1990.tb02015.x.Full Text Link to Item
-
Olsen, E. A., W. W. Weed, C. J. Meyer, and L. M. Cobo. “A double-blind, placebo-controlled trial of acitretin for the treatment of psoriasis.” J Am Acad Dermatol 21, no. 4 Pt 1 (October 1989): 681–86. https://doi.org/10.1016/s0190-9622(89)70236-x.Full Text Link to Item
-
Olsen, E. A. “Alopecia: evaluation and management.” Prim Care 16, no. 3 (September 1989): 765–87.Link to Item
-
Olsen, E. A., F. F. Kelly, R. T. Vollmer, D. A. Buddin, and P. K. Weck. “Comparative study of systemic interferon alfa-nl and isotretinoin in the treatment of resistant condylomata acuminata.” J Am Acad Dermatol 20, no. 6 (June 1989): 1023–30. https://doi.org/10.1016/s0190-9622(89)70127-4.Full Text Link to Item
-
Olsen, E. A., S. T. Rosen, R. T. Vollmer, D. Variakojis, H. H. Roenigk, N. Diab, and J. Zeffren. “Interferon alfa-2a in the treatment of cutaneous T cell lymphoma.” J Am Acad Dermatol 20, no. 3 (March 1989): 395–407. https://doi.org/10.1016/s0190-9622(89)70049-9.Full Text Link to Item
-
Weinstein, G. D., J. L. McCullough, and E. Olsen. “Topical methotrexate therapy for psoriasis.” Arch Dermatol 125, no. 2 (February 1989): 227–30.Link to Item
-
Olsen, E. A. “Reply.” Journal of the American Academy of Dermatology 20, no. 1 (January 1, 1989): 139. https://doi.org/10.1016/S0190-9622(89)80017-9.Full Text
-
Dang-Vu, A. P., E. A. Olsen, R. T. Vollmer, M. L. Greenberg, and M. S. Hershfield. “Treatment of cutaneous T cell lymphoma with 2'-deoxycoformycin (pentostatin).” J Am Acad Dermatol 19, no. 4 (October 1988): 692–98. https://doi.org/10.1016/s0190-9622(88)70224-8.Full Text Link to Item
-
Olsen, E. A., G. R. Lichtenstein, and W. E. Wilkinson. “Changes in serum lipids in patients with condylomata acuminata treated with interferon alfa-n1 (Wellferon).” J Am Acad Dermatol 19, no. 2 Pt 1 (August 1988): 286–89. https://doi.org/10.1016/s0190-9622(88)70173-5.Full Text Link to Item
-
Vernon, H. J., E. A. Olsen, and R. T. Vollmer. “Autosomal dominant multiple cylindromas associated with solitary lung cylindroma.” J Am Acad Dermatol 19, no. 2 Pt 2 (August 1988): 397–400. https://doi.org/10.1016/s0190-9622(88)70186-3.Full Text Link to Item
-
Olsen, E. A., J. R. Crawford, and R. T. Vollmer. “Sinus histiocytosis with massive lymphadenopathy. Case report and review of a multisystemic disease with cutaneous infiltrates.” J Am Acad Dermatol 18, no. 6 (June 1988): 1322–32. https://doi.org/10.1016/s0190-9622(88)70142-5.Full Text Link to Item
-
Olsen, E. A. “RX treatment for hair loss. Upjohn's Rogaine is the first FDA-approved product to treat male pattern baldness.” American Druggist 198, no. 4 (January 1, 1988): 75–76.
-
Kaplan, D. L., and E. A. Olsen. “Erosion of psoriatic plaques after chronic methotrexate administration.” Int J Dermatol 27, no. 1 (1988): 59–62. https://doi.org/10.1111/j.1365-4362.1988.tb02342.x.Full Text Link to Item
-
Olsen, E. A., and M. S. Weiner. “Topical minoxidil in male pattern baldness: effects of discontinuation of treatment.” J Am Acad Dermatol 17, no. 1 (July 1987): 97–101. https://doi.org/10.1016/s0190-9622(87)70179-0.Full Text Link to Item
-
Telfer, N. R., and R. P. Dawber. “Generalized pustular psoriasis associated with withdrawal of topical clobetasol-17-propionate.” J Am Acad Dermatol 17, no. 1 (July 1987): 144–45. https://doi.org/10.1016/s0190-9622(87)80553-4.Full Text Link to Item
-
Pestana, A., E. A. Olsen, E. R. Delong, and J. C. Murray. “Effect of ultraviolet light on topical minoxidil-induced hair growth in advanced male pattern baldness.” J Am Acad Dermatol 16, no. 5 Pt 1 (May 1987): 971–76. https://doi.org/10.1016/s0190-9622(87)70123-6.Full Text Link to Item
-
Olsen, E. A., E. R. DeLong, and M. S. Weiner. “Long-term follow-up of men with male pattern baldness treated with topical minoxidil.” J Am Acad Dermatol 16, no. 3 Pt 2 (March 1987): 688–95. https://doi.org/10.1016/s0190-9622(87)70089-9.Full Text Link to Item
-
Kuttner, B. J., K. J. Friedman, C. S. Burton, and E. A. Olsen. “Letterer-Siwe disease in an adult.” Cutis 39, no. 2 (February 1987): 142–46.Link to Item
-
Olsen, E. A. “Reply.” Journal of the American Academy of Dermatology 16, no. 1 (January 1, 1987): 145–46. https://doi.org/10.1016/S0190-9622(87)80188-3.Full Text
-
Olsen, E. A., E. DeLong, and M. S. Weiner. “Reply.” Journal of the American Academy of Dermatology 16, no. 2 (January 1, 1987): 393–94. https://doi.org/10.1016/S0190-9622(87)80142-1.Full Text
-
Bamford, J. T. “A falling out following minoxidil: telogen effluvium.” J Am Acad Dermatol 16, no. 1 Pt 1 (January 1987): 144–46. https://doi.org/10.1016/s0190-9622(87)80187-1.Full Text Link to Item
-
Olsen, E. A., and R. C. Cornell. “Topical clobetasol-17-propionate: review of its clinical efficacy and safety.” J Am Acad Dermatol 15, no. 2 Pt 1 (August 1986): 246–55. https://doi.org/10.1016/s0190-9622(86)70164-3.Full Text Link to Item
-
Olsen, E. A., E. R. DeLong, and M. S. Weiner. “Dose-response study of topical minoxidil in male pattern baldness.” J Am Acad Dermatol 15, no. 1 (July 1986): 30–37. https://doi.org/10.1016/s0190-9622(86)70138-2.Full Text Link to Item
-
OLSEN, E. A., and N. G. DIAB. “INTERFERON ALFA-2A IN THE TREATMENT OF CUTANEOUS T-CELL LYMPHOMA.” Journal of Investigative Dermatology 86, no. 4 (April 1, 1986): 498–498.Link to Item
-
Olsen, E. A., S. R. Pinnell, M. S. Weiner, and E. DeLong. “Reply.” Journal of the American Academy of Dermatology 14, no. 5 (January 1, 1986): 850–51. https://doi.org/10.1016/S0190-9622(86)80550-3.Full Text
-
Jegasothy, B., C. Jacobson, N. Levine, L. Millikan, E. Olsen, S. Pinnell, G. Cole, G. Weinstein, and M. Porter. “Clobetasol propionate versus fluocinonide creams in psoriasis and eczema.” International Journal of Dermatology 24, no. 7 (December 18, 1985): 461–65.
-
Baral, J. “Scalp comedones after topical minoxidil.” J Am Acad Dermatol 13, no. 6 (December 1985): 1051–52. https://doi.org/10.1016/s0190-9622(85)80495-3.Full Text Link to Item
-
Jegasothy, B., C. Jacobson, N. Levine, L. Millikan, E. Olsen, S. Pinnell, G. Cole, G. Weinstein, and M. Porter. “Clobetasol propionate versus fluocinonide creams in psoriasis and eczema.” Int J Dermatol 24, no. 7 (September 1985): 461–65. https://doi.org/10.1111/j.1365-4362.1985.tb05821.x.Full Text Link to Item
-
Olsen, E. A., M. S. Weiner, E. R. Delong, and S. R. Pinnell. “Topical minoxidil in early male pattern baldness.” J Am Acad Dermatol 13, no. 2 Pt 1 (August 1985): 185–92. https://doi.org/10.1016/s0190-9622(85)70157-0.Full Text Link to Item
-
OLSEN, E. A., K. F. TROFATTER, S. A. GALL, J. R. MEDOFF, C. E. HUGHES, M. S. WEINER, and F. F. KELLY. “HUMAN-LYMPHOBLASTOID ALPHA-INTERFERON IN THE TREATMENT OF REFRACTORY CONDYLOMA ACUMINATA.” Journal of Investigative Dermatology 84, no. 4 (January 1, 1985): 359–359.Link to Item
-
Olsen, E. A., E. Delzell, and B. V. Jegasothy. “Second malignancies in cutaneous T cell lymphoma.” J Am Acad Dermatol 10, no. 2 Pt 1 (February 1984): 197–204. https://doi.org/10.1016/s0190-9622(84)70023-5.Full Text Link to Item
-
OLSEN, E. A., B. V. JEGASOTHY, and B. F. HAYNES. “PARA-PSORIASIS EN PLAQUES - PHENOTYPIC ANALYSIS OF CUTANEOUS T-CELL INFILTRATES.” Journal of Investigative Dermatology 78, no. 4 (January 1, 1982): 337–337.Link to Item
-
OLSEN, E. A., B. V. JEGASOTHY, and B. F. HAYNES. “PARA-PSORIASIS EN PLAQUES - PHENOTYPIC ANALYSIS OF CUTANEOUS T-CELL INFILTRATES.” Clinical Research 30, no. 2 (January 1, 1982): A600–A600.Link to Item
-
-
Book Sections
-
Yeager, Caroline, and Elise A. Olsen. “Hair Disorders Associated with Anticancer Agents.” In DERMATOLOGIC PRINCIPLES AND PRACTICE IN ONCOLOGY: CONDITIONS OF THE SKIN, HAIR, AND NAILS IN CANCER PATIENTS, 100–114, 2014.Link to Item
-
Olsen, Elise A. “Chemotherapy-Induced Alopecia: Overview and Methodology for Characterizing Hair Changes and Regrowth.” In The MASCC Textbook of Cancer Supportive Care and Survivorship, 381–86. Springer US, 2010. https://doi.org/10.1007/978-1-4419-1225-1_36.Full Text
-
-
Conference Papers
-
Svoboda, Ryan M., and Elise A. Olsen. “The necessity of a comprehensive physical examination in cutaneous T-cell lymphoma: A series of three patients with occult Hodgkin's lymphoma.” In Journal of the American Academy of Dermatology, 81:AB286–AB286. MOSBY-ELSEVIER, 2019.Link to Item
-
Duvic, Madeleine, Ann Martin, Elise A. Olsen, David Fivenson, and Miles Prince. “Efficacy of Denileukin Diftitox Retreatment In Patients with Cutaneous T-Cell Lymphoma Who Relapsed After Initial Response.” In Blood, 116:1179–1179. AMER SOC HEMATOLOGY, 2010.Link to Item
-
Olsen, E. A., K. B. Reed, P. B. Cacchio, and L. Caudill. “Iron deficiency in female pattern hair loss, chronic telogen effluvium and control groups Hormones, Hair Growth and Pattern Hair Loss.” In Experimental Dermatology, 19:572–572. WILEY-BLACKWELL PUBLISHING, INC, 2010.Link to Item
-
Olsen, E. A., A. McMichael, V. Callender, L. Sperling, K. Anstrom, J. Shapiro, J. Roberts, et al. “Central hair loss in African American women Stem Cells, Stem Cell Niches and Cicatricial Alopecia.” In Experimental Dermatology, 19:568–69. WILEY-BLACKWELL PUBLISHING, INC, 2010.Link to Item
-
Thomas, K. A., P. B. Cacchio, and E. A. Olsen. “Evaluation of the long-term (> 10-year) progression of male pattern hair loss.” In Experimental Dermatology, 19:583–583. WILEY-BLACKWELL PUBLISHING, INC, 2010.Link to Item
-
Duvic, Madeleine, Youn H. Kim, Timothy M. Kuzel, Theresa R. Pacheco, Francine M. Foss, Sareeta Parker, Syed Rizvi, Cong Chen, Jean Marie Arduino, and Elise A. Olsen. “The Systemic Effects of Vorinostat in Patients (Pts) with Cutaneous T-Cell Lymphoma (CTCL): Post-Hoc Analyses in Pts with High Blood Tumor Burden.” In Blood, 114:681–681. AMER SOC HEMATOLOGY, 2009.Link to Item
-
Foss, Francine, Madeleine Duvic, Elise A. Olsen, and Anna Kozlovski. “Complete Responses with Denileukin Diftitox in Cutaneous T-Cell Lymphoma Studies.” In Blood, 114:1441–42. AMER SOC HEMATOLOGY, 2009.Link to Item
-
Duvic, M., E. A. Olsen, D. Breneman, T. R. Pacheco, S. Parker, E. C. Vonderheid, J. L. Ricker, et al. “VORINOSTAT PROVIDES PROLONGED SAFETY AND CLINICAL BENEFIT TO PATIENTS WITH ADVANCED CUTANEOUS T-CELL LYMPHOMA (CTCL).” In Haematologica, 93:107–8. FERRATA STORTI FOUNDATION, 2008.Link to Item
-
Olsen, E. A., S. Rizvi, J. Garcia-Vargas, C. Sanz-Rodriguez, J. Viscusi, M. Gates, and M. Duvic. “SUMMARY OF THE CLINICAL BENEFIT OF VORINOSTAT IN RELAPSED/REFRACTORY CTCL.” In Haematologica, 93:176–176. FERRATA STORTI FOUNDATION, 2008.Link to Item
-
Duvic, M., E. A. Olsen, D. Breneman, T. R. Pacheco, S. Parker, E. C. Vonderheid, J. L. Ricker, et al. “Vorinostat provides prolonged safety and clinical benefit to patients with advanced CTCL.” In Annals of Oncology, 19:161–161. OXFORD UNIV PRESS, 2008.Link to Item
-
Olsen, E. A., and M. Duvic. “Clinical efficacy and safety of vorinostat in relapsed/refractory CTCL.” In Annals of Oncology, 19:156–156. OXFORD UNIV PRESS, 2008.Link to Item
-
Duvic, Madeleine, Elise A. Olsen, Debra Breneman, Theresa R. Pacheco, Sardeta Parker, Eric C. Vonderheid, Justin L. Ricker, et al. “Vorinostat (suberoylanilide hydroxamic acid, SAHA) provides prolonged safety and clinical benefit to patients with advanced cutaneous T-cell lymphoma (CTCL).” In Blood, 110:761A-761A. AMER SOC HEMATOLOGY, 2007.Link to Item
-
Duvic, Madeleine, Youn H. Kim, Timothy M. Kuzel, Theresa R. Pacheco, Francine M. Foss, Sareeta Parker, Stanley R. Frankel, et al. “Vorinostat (Suberoylanilide hydroxamic acid, SAHA) provides prolonged clinical benefit to advanced cutaneous T-Cell lymphoma patients: Updated results of the phase IIb multicenter clinical trial.” In Blood, 108:122A-122A. AMER SOC HEMATOLOGY, 2006.Link to Item
-
Duvic, M., F. M. Foss, E. A. Olsen, A. Forero-Torres, J. C. Bennett, S. Bantia, and J. M. Kilpatrick. “Intravenous forodesine (BCX-1777), a novel purine nucleoside phosphorylase (PNP) inhibitor, demonstrates clinical activity in patients with refractory cutaneous T-cell lymphoma.” In Blood, 104:683A-683A. AMER SOC HEMATOLOGY, 2004.Link to Item
-
Duvic, M., S. Ziari, E. A. Olsen, and F. M. Foss. “Phase 1-2 multi-center study of intravenous Bcx-1777 in patients with refractory cutaneous T-cell lymphoma.” In Journal of Clinical Oncology, 22:615S-615S. AMER SOC CLINICAL ONCOLOGY, 2004.Link to Item
-
LIGHTNER, V. A., T. J. BUCHSBAUM, and E. A. OLSEN. “TENASCIN (HEXABRACHION) IS INCREASED IN LESIONAL PSORIATIC SKIN.” In Journal of Investigative Dermatology, 96:563–563. BLACKWELL PUBLISHING INC, 1991.Link to Item
-
LIGHTNER, V. A., T. J. BUCHSBAUM, and E. A. OLSEN. “TENASCIN (HEXABRACHION) IS INCREASED IN LESIONAL PSORIATIC SKIN.” In Clinical Research, 39:A490–A490. SLACK INC, 1991.Link to Item
-
OLSEN, E. A., S. J. ROSEN, and H. H. ROENIGK. “INTERFERON ALFA-2A IN THE TREATMENT OF CUTANEOUS T-CELL LYMPHOMA.” In Journal of Investigative Dermatology, 94:561–561. BLACKWELL SCIENCE INC, 1990.Link to Item
-
OLSEN, E. A., S. J. ROSEN, and H. H. ROENIGK. “INTERFERON-ALPHA-2A IN THE TREATMENT OF CUTANEOUS T-CELL LYMPHOMA.” In Clinical Research, 38:A627–A627. SLACK INC, 1990.Link to Item
-
OLSEN, E. A., and N. G. DIAB. “INTERFERON ALFA-2A IN THE TREATMENT OF CUTANEOUS T-CELL LYMPHOMA.” In Clinical Research, 34:A772–A772. SLACK INC, 1986.Link to Item
-
OLSEN, E. A., K. F. TROFATTER, S. A. GALL, J. R. MEDOFF, C. E. HUGHES, M. S. WEINER, and F. F. KELLY. “HUMAN-LYMPHOBLASTOID ALPHA-INTERFERON IN THE TREATMENT OF REFRACTORY CONDYLOMA ACUMINATA.” In Clinical Research, 33:A673–A673. SLACK INC, 1985.Link to Item
-
-
- Scholarly, Clinical, & Service Activities
-
Service to Duke
- Misconduct in Research. 2002 - 2027 2002 - 2027
- IRB. 1992 - 2004 1992 - 2004
Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.